Matches in Wikidata for { <http://www.wikidata.org/entity/Q93422467> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q93422467 description "clinical trial" @default.
- Q93422467 description "ensayo clínico" @default.
- Q93422467 description "ensayu clínicu" @default.
- Q93422467 description "klinisch onderzoek" @default.
- Q93422467 description "клінічне випробування" @default.
- Q93422467 description "临床试验" @default.
- Q93422467 name "A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications" @default.
- Q93422467 name "A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications" @default.
- Q93422467 type Item @default.
- Q93422467 label "A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications" @default.
- Q93422467 label "A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications" @default.
- Q93422467 prefLabel "A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications" @default.
- Q93422467 prefLabel "A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications" @default.
- Q93422467 P1132 Q93422467-886842AA-6415-4D1E-99DD-7A9D5401FC11 @default.
- Q93422467 P1476 Q93422467-FEB19C6F-C55A-4F1E-9BF3-41D0C5471256 @default.
- Q93422467 P17 Q93422467-CF2FF1B0-182E-4C7B-8778-FD110A178A29 @default.
- Q93422467 P2899 Q93422467-44C0AF60-30FE-4D0E-99BB-5064C26EE207 @default.
- Q93422467 P3098 Q93422467-ED4325FD-C3BA-484D-A5E0-38E973916D5B @default.
- Q93422467 P31 Q93422467-E1FA0C6A-4418-4619-BE51-578A41351B24 @default.
- Q93422467 P4135 Q93422467-BD435FAB-1622-42AE-B1AD-BB0C65B28B29 @default.
- Q93422467 P580 Q93422467-73FC784F-3037-46AB-BD8B-9FF16A52B679 @default.
- Q93422467 P582 Q93422467-8CD880E8-EF83-42A5-8D4C-11B04D543A7A @default.
- Q93422467 P6099 Q93422467-59518A69-ECE1-497F-AEFD-2F86BCC166E4 @default.
- Q93422467 P8005 Q93422467-7D41A07D-17BF-40FA-A93B-7FF21472B80A @default.
- Q93422467 P8363 Q93422467-017D0235-BB28-4D14-9207-7B1D45541DA3 @default.
- Q93422467 P1132 "+100" @default.
- Q93422467 P1476 "A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications" @default.
- Q93422467 P17 Q668 @default.
- Q93422467 P2899 "+18" @default.
- Q93422467 P3098 "NCT04374487" @default.
- Q93422467 P31 Q30612 @default.
- Q93422467 P4135 "+85" @default.
- Q93422467 P580 "2020-05-09T00:00:00Z" @default.
- Q93422467 P582 "2021-05-09T00:00:00Z" @default.
- Q93422467 P6099 Q42824440 @default.
- Q93422467 P8005 Q76649614 @default.
- Q93422467 P8363 Q78089383 @default.